Immune activation and neuropsychiatric symptoms in HIV infection

J Neuropsychiatry Clin Neurosci. 2010 Summer;22(3):321-8. doi: 10.1176/jnp.2010.22.3.321.

Abstract

This study examined the role of biological processes in the development of specific neuropsychiatric complications in HAART-naive adults with HIV/AIDS. Depressive symptoms were modestly associated with elevated IL-6 mRNA expression (r(s)=0.40, p<0.05) even after removing the influences of other subjective complaints (pr=0.39, p<0.05). Elevated serum neopterin was strongly associated with depressive symptoms in individuals taking antidepressants (r(s)=0.83, p<0.001), though the association was nullified in those not on antidepressants (r(s)=-0.25, p>0.05). Mean neopterin levels were higher in the depressed as compared with nondepressed group but only for those taking antidepressants (F=45.66, df=1, 11, p<0.001). Neuropsychological impairment was not associated with the biological markers. These findings suggest that systemic immune markers (like neopterin) may be useful in differentiating treatment-resistant individuals at greater risk of developing chronic depression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analysis of Variance
  • Depression / complications*
  • Depression / immunology
  • Depression / psychology
  • HIV Infections / complications*
  • HIV Infections / immunology
  • HIV Infections / psychology
  • Humans
  • Interleukin-6 / blood
  • Interleukin-6 / immunology*
  • Neopterin / blood
  • Neopterin / immunology
  • Neuropsychological Tests
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Necrosis Factor-alpha / blood
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Neopterin